Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

Pfizer, Novo Nordisk Locked in High-Stakes Fight Over Obesity Drug Innovator Metsera

The Pfizer building is seen January 22, 2007 in New York City. In an effort to galvanize earnings, the drug company has announced that they will lay off 10,000 workers and close several manufacturing and research sites.

Pfizer and Novo Nordisk are locked in a high-stakes battle to acquire US obesity drug developer Metsera, sending shockwaves through the pharmaceutical industry.

The two giants have submitted competing bids, with Metsera calling Novo's $10 billion offer "superior."

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.